These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 9267827

  • 1. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T, Iwamoto Y, Shinohara N, Ushijima M, Chuman H, Tsuneyoshi M.
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [Abstract] [Full Text] [Related]

  • 2. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
    Ariizumi T, Ogose A, Kawashima H, Hotta T, Li G, Xu Y, Umezu H, Sugai M, Endo N.
    Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
    [Abstract] [Full Text] [Related]

  • 3. Detection of c-fos expression in benign and malignant musculoskeletal lesions.
    Weisstein JS, Majeska RJ, Klein MJ, Einhorn TA.
    J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843
    [Abstract] [Full Text] [Related]

  • 4. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.
    Scotlandi K, Baldini N, Oliviero M, Di Renzo MF, Martano M, Serra M, Manara MC, Comoglio PM, Ferracini R.
    Am J Pathol; 1996 Oct; 149(4):1209-19. PubMed ID: 8863670
    [Abstract] [Full Text] [Related]

  • 5. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
    Oda Y, Naka T, Takeshita M, Iwamoto Y, Tsuneyoshi M.
    Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
    [Abstract] [Full Text] [Related]

  • 6. Primary bone tumors. MR morphologic appearance correlated with pathologic examinations.
    Golfieri R, Baddeley H, Pringle JS, Leung AW, Greco A, Souhami R, Kemp H.
    Acta Radiol; 1991 Jul; 32(4):290-8. PubMed ID: 1650569
    [Abstract] [Full Text] [Related]

  • 7. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
    Huse JT, Pasha TL, Zhang PJ.
    Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
    [Abstract] [Full Text] [Related]

  • 8. Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype.
    Radig K, Häckel C, Herting J, Oda Y, Mittler U, Neumann W, Roessner A.
    Gen Diagn Pathol; 1997 Feb; 142(3-4):139-45. PubMed ID: 9065577
    [Abstract] [Full Text] [Related]

  • 9. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
    Roessner A, Grundmann E.
    Veroff Pathol; 1984 Feb; 122():1-195. PubMed ID: 6091360
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A, Yamamoto Y, Tsuneyama K, Cheng C, Yonekura H, Watanabe T, Shimizu K, Tomita K, Yamamoto H, Tsuchiya H.
    Cancer; 2007 Jun 15; 109(12):2532-40. PubMed ID: 17497647
    [Abstract] [Full Text] [Related]

  • 12. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y, Liang Q, Wen YQ, Chen LL, Wang LT, Liu YL, Luo CQ, Liang HZ, Li MT, Li Z.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):97-106. PubMed ID: 20362224
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activators and their inhibitor in osteosarcomas and other bone tumors.
    Häkel C, Ueda Y, Tsuchya H, Herrera A, Blasius S, Roessner A.
    Zentralbl Pathol; 1994 Nov 15; 140(4-5):363-9. PubMed ID: 7826985
    [Abstract] [Full Text] [Related]

  • 14. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Sciot R, Van den Berghe H, Vanni R, Willén H.
    J Pathol; 2002 Feb 15; 196(2):194-203. PubMed ID: 11793371
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
    Weinberger PM, Yu Z, Kowalski D, Joe J, Manger P, Psyrri A, Sasaki CT.
    Arch Otolaryngol Head Neck Surg; 2005 Aug 15; 131(8):707-11. PubMed ID: 16103303
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
    Kilpatrick SE, Geisinger KR, King TS, Sciarrotta J, Ward WG, Gold SH, Bos GD.
    Mod Pathol; 2001 Dec 15; 14(12):1277-83. PubMed ID: 11743051
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.
    Oda Y, Walter H, Radig K, Röse I, Neumann W, Roessner A.
    J Cancer Res Clin Oncol; 1995 Dec 15; 121(11):667-73. PubMed ID: 7593131
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
    Matsuura S, Oda Y, Matono H, Izumi T, Yamamoto H, Tamiya S, Iwamoto Y, Tsuneyoshi M.
    Hum Pathol; 2010 Mar 15; 41(3):343-51. PubMed ID: 19896699
    [Abstract] [Full Text] [Related]

  • 19. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Rushing EJ.
    Hum Pathol; 2010 May 15; 41(5):653-62. PubMed ID: 20138330
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of 1355 cases of tumors and tumor-like lesions in the bone].
    He XH.
    Zhonghua Zhong Liu Za Zhi; 1990 Jan 15; 12(1):66-8. PubMed ID: 2364876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.